Emgality is a medicine used to prevent migraine in adults who have migraines at least 4 days a month. It contains the active substance galcanezumab.
Therapeutic Indication
### Therapeutic indication Emgality is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
Therapeutic Area (MeSH)
ATC Code
N02
ATC Item
镇痛药
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Galcanezumab | N/A | 加卡奈珠单抗 |
EMA Name
Emgality
Medicine Name
Emgality
Aliases
N/ANo risk management plan link.
